| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbdc68ca0aa38fef2d059853ef2b31e6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
| filingDate |
2017-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_124e1f0cb18abe58706b2683ca05ba9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c4fe8ed26486a916dc24d8f2bcad960
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85a98b1912da425e735f4e02aa2192b8 |
| publicationDate |
2018-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9980925-B2 |
| titleOfInvention |
Xanthohumol in antiarrythmic applications |
| abstract |
Methods for modulating Ca 2+ signaling in cardiac myocytes by use of xanthohumol are described. Xanthohumol can suppress Ca 2+ signaling by suppressing spontaneous activity of the RyR2 receptor. Delivery of xanthohumol to a cardiocyte can be utilized in treatment of cardiac arrhythmia. |
| priorityDate |
2016-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |